Jennifer S McDaniel1, Marcello Pilia1, Catherine L Ward1, Beth E Pollot2, Christopher R Rathbone3. 1. Extremity Trauma and Regenerative Medicine Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas. 2. Extremity Trauma and Regenerative Medicine Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas; Department of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, Texas. 3. Extremity Trauma and Regenerative Medicine Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas. Electronic address: christopher.r.rathbone.civ@mail.mil.
Abstract
BACKGROUND: A number of therapies are being developed that use microvessels isolated from adipose tissue (microvascular fragments [MVFs]) to improve tissue perfusion and implant survival. Because it has been demonstrated that stem cells are associated with microvessels, the purpose of these studies was to gain further insight into the stem cells associated with MVFs to better understand their therapeutic potential. MATERIALS AND METHODS: Cells derived from MVF explants were compared with adipose-derived stem cells (ASCs) based on the expression of cell surface proteins for mesenchymal stem cells and their capacity for angiogenic, neurogenic, adipogenic, and osteogenic differentiation. RESULTS: The expression of cell surface proteins for mesenchymal stem cell markers was similar between MVF-derived cells and ASCs; however, the increase in markers consistent with endothelial cells and pericytes was accompanied by an improved ability to form capillary-like networks when cultured on matrigel. MVF-derived cells had increased neuregulin, leptin, and osteopontin expression compared with ASCs when exposed to neurogenic, adipogenic, and osteogenic induction media, respectively. CONCLUSIONS: The stem cell functionality of cells derived from MVFs is retained after their isolation. This helps to explain the ability of MVFs to improve tissue perfusion and has implications for the use of MVFs as a means to deliver stem cells within their niche. Published by Elsevier Inc.
BACKGROUND: A number of therapies are being developed that use microvessels isolated from adipose tissue (microvascular fragments [MVFs]) to improve tissue perfusion and implant survival. Because it has been demonstrated that stem cells are associated with microvessels, the purpose of these studies was to gain further insight into the stem cells associated with MVFs to better understand their therapeutic potential. MATERIALS AND METHODS: Cells derived from MVF explants were compared with adipose-derived stem cells (ASCs) based on the expression of cell surface proteins for mesenchymal stem cells and their capacity for angiogenic, neurogenic, adipogenic, and osteogenic differentiation. RESULTS: The expression of cell surface proteins for mesenchymal stem cell markers was similar between MVF-derived cells and ASCs; however, the increase in markers consistent with endothelial cells and pericytes was accompanied by an improved ability to form capillary-like networks when cultured on matrigel. MVF-derived cells had increased neuregulin, leptin, and osteopontin expression compared with ASCs when exposed to neurogenic, adipogenic, and osteogenic induction media, respectively. CONCLUSIONS: The stem cell functionality of cells derived from MVFs is retained after their isolation. This helps to explain the ability of MVFs to improve tissue perfusion and has implications for the use of MVFs as a means to deliver stem cells within their niche. Published by Elsevier Inc.
Authors: Evan Paul Tracy; Virginia Stielberg; Gabrielle Rowe; Daniel Benson; Sara S Nunes; James B Hoying; Walter Lee Murfee; Amanda Jo LeBlanc Journal: Am J Physiol Heart Circ Physiol Date: 2022-02-18 Impact factor: 4.733
Authors: Francisca M Acosta; Katerina Stojkova; Jingruo Zhang; Eric Ivan Garcia Huitron; Jean X Jiang; Christopher R Rathbone; Eric M Brey Journal: J Tissue Eng Date: 2022-06-24 Impact factor: 7.940
Authors: Florian S Frueh; Thomas Später; Claudia Scheuer; Michael D Menger; Matthias W Laschke Journal: J Vis Exp Date: 2017-04-30 Impact factor: 1.355
Authors: Francisca M Acosta; Kennedy K Howland; Katerina Stojkova; Elizabeth Hernandez; Eric M Brey; Christopher R Rathbone Journal: Tissue Eng Part A Date: 2021-08-25 Impact factor: 3.845
Authors: M A Ruehle; E A Eastburn; S A LaBelle; L Krishnan; J A Weiss; J D Boerckel; L B Wood; R E Guldberg; N J Willett Journal: Sci Adv Date: 2020-08-21 Impact factor: 14.136